Related Experiment Video
Updated: Jan 2, 2026
07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
8.4K
The First 48 Consecutive Patients with 3-Year Symptom Score Follow-Up Post-Prostate Artery Embolization (PAE) at a
Drew Maclean1, Mark Harris2, Joe Long3
1Department of Interventional Radiology, University Hospital Southampton, Southampton, UK. drew.maclean@uhs.nhs.uk.
Cardiovascular and Interventional Radiology
|December 5, 2019
Summary
Prostate artery embolization (PAE) shows sustained symptomatic relief at 3 years, with a high clinical success rate and minimal need for repeat surgery. Most patients experience stable symptom scores beyond the initial 12-month follow-up.
Area of Science:
- Interventional Radiology
- Urology
- Vascular Surgery
Background:
- Limited long-term follow-up data exists for prostate artery embolization (PAE).
- Evaluating the sustained efficacy of PAE beyond 12 months is crucial for patient management.
Purpose of the Study:
- To assess the symptomatic effectiveness of PAE up to 3 years post-procedure.
- To determine the long-term clinical success rate and need for subsequent interventions.
Main Methods:
- Retrospective analysis of 48 consecutive patients who underwent PAE.
- Urodynamic studies to confirm bladder outflow obstruction prior to PAE.
- International Prostate Symptom Score (IPSS) and Quality of Life (QOL) assessment at baseline, 3 months, 12 months, and 3 years.
Main Results:
- Technical success (bilateral embolization) achieved in 89.6% of patients.
- A 71.8% clinical success rate at 3 years was observed, with only 11/39 patients requiring surgery.
- No significant worsening of IPSS or QOL scores was noted between 1 and 3 years for patients not undergoing surgery.
Conclusions:
- PAE demonstrates high and sustained clinical success at 3 years.
- The need for surgical intervention or symptom recurrence after 12 months is low.
- PAE is an effective long-term treatment option for benign prostatic hyperplasia (BPH).
